Once serving a short stay at the FDA head Robert Califf has not spoken on concerns with cannabis.
“We understand that people have identified a number of possible uses of marijuana and marijuana-derived products.
“What this means is that no one has demonstrated to FDA that any such product is safe or effective for the treatment of any disease or condition.
The approval of these substances “supports the point I made earlier that our decisions on the approval of any medicine relies on the science to determine the safety and effectiveness of new medicines.
In its entirety, the comments imply that, if confirmed, Califf wouldn’t be opposed to examining the healing powers of cannabis.
Mainly this was done as a way to mitigate the risks of the e-cigarette or vaping use-associated lung injury crisis.
If all goes well the FDA may allow CBD to be marketed as a food item or dietary supplement.
A process that would need to be done before submitting that examination to the Justice Department with its recommendations.